title: Simvastatin reduces activation of normal platelets by LDL isolated from patients with familial hypercholesterolaemia and familial defective apolipoprotein B.
authors.forename: D A
authors.initials: DA
authors.lastname: Tsakiris
authors.forename: U
authors.initials: U
authors.lastname: Keller
authors.forename: H
authors.initials: H
authors.lastname: Zulewski
authors.forename: A R
authors.initials: AR
authors.lastname: Miserez
authors.forename: F
authors.initials: F
authors.lastname: Wolf
authors.forename: G A
authors.initials: GA
authors.lastname: Marbet
mesh_terms: D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001055:Apolipoproteins B / Q000172:deficiency*; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood* / Q000188:drug therapy; D008077:Lipoproteins, LDL / Q000494:pharmacology*; D008875:Middle Aged; D015539:Platelet Activation / Q000187:drug effects*; D019821:Simvastatin / Q000494:pharmacology*
chemical_list: D000924:Anticholesteremic Agents; D001055:Apolipoproteins B; D008077:Lipoproteins, LDL; D019821:Simvastatin